The 20-year impact of tobacco price and tobacco control expenditure increases in Minnesota, 1998-2017

PLoS One. 2020 Mar 18;15(3):e0230364. doi: 10.1371/journal.pone.0230364. eCollection 2020.

Abstract

Introduction: Tobacco control programs and policies reduce tobacco use and prevent health and economic harms. The majority of tobacco control programs and policies in the United States are implemented at local and state levels. Yet the literature on state-level initiatives reports a limited set of outcomes. To facilitate decision-making that is increasingly focused on costs, we provide estimates of a broader set of measures of the impact of tobacco control policy, including smoking prevalence, disease events, deaths, medical costs, productivity and tobacco tax revenues, using the experience of Minnesota as an example.

Methods: Using the HealthPartners Institute's ModelHealth™: Tobacco MN microsimulation, we assessed the impact of the stream of tobacco control expenditures and cigarette price increases from 1998 to 2017. We simulated 1.3 million individuals representative of the Minnesota population.

Results: The simulation estimated that increased expenditures on tobacco control above 1997 levels prevented 38,400 cancer, cardiovascular, diabetes and respiratory disease events and 4,100 deaths over 20 years. Increased prices prevented 14,600 additional events and 1,700 additional deaths. Both the net increase in tax revenues and the reduction in medical costs were greater than the additional investments in tobacco control.

Conclusion: Combined, the policies address both short-term and long-term goals to reduce the harms of tobacco by helping adults who wish to quit smoking and deterring youth from starting to smoke. States can pay for initial investments in tobacco control through tax increases and recoup those investments through reduced expenditures on medical care.

Publication types

  • Historical Article
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Child
  • Commerce / economics*
  • Commerce / history
  • Commerce / legislation & jurisprudence
  • Commerce / statistics & numerical data
  • Computer Simulation
  • Female
  • Fiscal Policy / history
  • Health Expenditures / history
  • Health Expenditures / statistics & numerical data
  • History, 20th Century
  • History, 21st Century
  • Humans
  • Male
  • Minnesota / epidemiology
  • Models, Biological
  • Models, Economic
  • Mortality / history
  • Prevalence
  • Smoking Prevention / economics*
  • Smoking Prevention / history
  • Smoking Prevention / methods
  • Taxes / history
  • Taxes / legislation & jurisprudence*
  • Tobacco Products / adverse effects
  • Tobacco Products / economics*
  • Tobacco Products / history
  • Tobacco Products / legislation & jurisprudence
  • Tobacco Smoking / adverse effects
  • Tobacco Smoking / economics
  • Tobacco Smoking / epidemiology
  • Tobacco Smoking / prevention & control*
  • Young Adult

Grants and funding

This study was funded by ClearWay Minnesota℠, an independent nonprofit organization funded with three percent of Minnesota’s tobacco settlement. ClearWay Minnesota works to reduce the harm of tobacco through research, action and collaboration and, as part of its work, funds and administers QUITPLAN Services (Minnesota’s free quitline). All authors (ClearWay Minnesota, HealthPartners, and Truth Initiative) contributed to the study design. HealthPartners collected and analyzed the data, and led the interpretation of findings. All authors contributed to the writing of this report and decided to submit the article for publication.